{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:44:35Z","timestamp":1790649875279,"version":"4.1.0"},"reference-count":65,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7624","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:36:46Z","timestamp":1559043406000},"source":"Crossref","is-referenced-by-count":4,"title":["Psoriasis: Association of interleukin-17 gene polymorphisms with severity and response to treatment (Review)"],"prefix":"10.3892","author":[{"given":"Alexandra","family":"Pu\u0219ca\u0219","sequence":"first","affiliation":[{"name":"Department of Physiology, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"C\u0103tan\u0103","sequence":"additional","affiliation":[{"name":"Department of Genetics, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Pu\u0219ca\u0219","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Roman","sequence":"additional","affiliation":[{"name":"Department of Physiology, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Vornicescu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"\u0218omlea","sequence":"additional","affiliation":[{"name":"Department of Dermatology, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remus","family":"Or\u0103san","sequence":"additional","affiliation":[{"name":"Department of Physiology, \u02bbIuliu Ha\u021bieganu\u02bc University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"key20200713100337_b1-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/cei.12888","article-title":"A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population","volume":"187","author":"Kim","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"key20200713100337_b2-etm-0-0-7624","first-page":"1241","article-title":"Assessment of dermal papillary and microvascular parameters in psoriasis vulgaris using in vivo reflectance confocal microscopy","volume":"15","author":"Batani","year":"2018","journal-title":"Exp Ther Med"},{"key":"key20200713100337_b3-etm-0-0-7624","first-page":"704","article-title":"Assessment of some oxidative stress parameters in methotrexate treated psoriasis patients","volume":"62","author":"Boda","year":"2014","journal-title":"Farmacia"},{"key":"key20200713100337_b4-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jdermsci.2015.06.011","article-title":"Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and psoriasis in a Spanish cohort","volume":"80","author":"Batalla","year":"2015","journal-title":"J Dermatol Sci"},{"key":"key20200713100337_b5-etm-0-0-7624","first-page":"1191","article-title":"Boda D, C\u0103runtu A, Rotaru M, Baderca F and Zurac S: In vivo imaging techniques for psoriatic lesions","volume":"55","author":"C\u0103runtu","year":"2014","journal-title":"Rom J Morphol Embryol"},{"key":"key20200713100337_b6-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/09546634.2017.1422591","article-title":"A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12\/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis","volume":"29","author":"Bilal","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"key20200713100337_b7-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/jid.2011.14","article-title":"New psoriasis susceptibility genes: Momentum for skin-barrier disruption","volume":"131","author":"Coto","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b8-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"key":"key20200713100337_b9-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1038\/ncomms7916","article-title":"Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility","volume":"6","author":"Yin","year":"2015","journal-title":"Nat Commun"},{"key":"key20200713100337_b10-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: A comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"key20200713100337_b11-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Genet"},{"key":"key20200713100337_b12-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.jid.2016.03.047","article-title":"The molecular revolution in cutaneous biology: The era of genome-wide association studies and statistical, big data, and computational topics","volume":"137","author":"Anbunathan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b13-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"251","DOI":"10.2147\/CCID.S67534","article-title":"Targeting of interleukin-17 in the treatment of psoriasis","volume":"7","author":"L\u00f8nnberg","year":"2014","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"key20200713100337_b14-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/09546634.2013.879093","article-title":"The role of IL-17 in psoriasis","volume":"26","author":"Malakouti","year":"2015","journal-title":"J Dermatolog Treat"},{"key":"key20200713100337_b15-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713100337_b16-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jdermsci.2008.09.003","article-title":"IL-17F single nucleotide polymorphism is not associated with psoriasis vulgaris or atopic dermatitis in the Japanese population","volume":"53","author":"Shibata","year":"2009","journal-title":"J Dermatol Sci"},{"key":"key20200713100337_b17-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: Rationale for targeting interleukin-17","volume":"167","author":"Girolomoni","year":"2012","journal-title":"Br J Dermatol"},{"key":"key20200713100337_b18-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"key20200713100337_b19-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0083-6729(06)74010-9","article-title":"The IL-17 cytokine family","volume":"74","author":"Gaffen","year":"2006","journal-title":"Vitam Horm"},{"key":"key20200713100337_b20-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"key20200713100337_b21-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","article-title":"Th17 cells in human disease","volume":"223","author":"Tesmer","year":"2008","journal-title":"Immunol Rev"},{"key":"key20200713100337_b22-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"ii116","DOI":"10.1136\/annrheumdis-2012-202371","article-title":"Effect of IL-17A blockade with secukinumab in autoimmune diseases","volume":"72","author":"Patel","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"key20200713100337_b23-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1002\/art.27622","article-title":"Role of Th17 cells in human autoimmune arthritis","volume":"62","author":"Leipe","year":"2010","journal-title":"Arthritis Rheum"},{"key":"key20200713100337_b24-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"key20200713100337_b25-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.coi.2011.07.006","article-title":"Recent advances in the IL-17 cytokine family","volume":"23","author":"Gaffen","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"key20200713100337_b26-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2586","article-title":"Structure and signalling in the IL-17 receptor family","volume":"9","author":"Gaffen","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key20200713100337_b27-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.4049\/jimmunol.181.4.2799","article-title":"The human IL-17F\/IL-17A heterodimeric cytokine signals through the IL-17RA\/IL-17RC receptor complex","volume":"181","author":"Wright","year":"2008","journal-title":"J Immunol"},{"key":"key20200713100337_b28-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0001-7310(14)70014-6","article-title":"Pathogenic role of IL-17 in psoriasis and psoriatic arthritis","volume":"105","author":"Chiricozzi","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"key20200713100337_b29-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"4137","DOI":"10.4049\/jimmunol.167.8.4137","article-title":"Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production","volume":"167","author":"Starnes","year":"2001","journal-title":"J Immunol"},{"key":"key20200713100337_b30-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10875-007-9125-8","article-title":"The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis","volume":"28","author":"Arisawa","year":"2008","journal-title":"J Clin Immunol"},{"key":"key20200713100337_b31-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jaci.2004.10.019","article-title":"IL-17 cytokine family","volume":"114","author":"Kawaguchi","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"key20200713100337_b32-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2217\/pgs.15.107","article-title":"The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis","volume":"16","author":"Prieto-P\u00e9rez","year":"2015","journal-title":"Pharmacogenomics"},{"key":"key20200713100337_b33-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b34-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/tpj.2016.70","article-title":"IL17RA gene variants and anti-TNF response among psoriasis patients","volume":"18","author":"Batalla","year":"2018","journal-title":"Pharmacogenomics J"},{"key":"key20200713100337_b35-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b36-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b37-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2217\/imt-2017-0077","article-title":"A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis","volume":"9","author":"Roostaeyan","year":"2017","journal-title":"Immunotherapy"},{"key":"key20200713100337_b38-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"key20200713100337_b39-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"e14299","DOI":"10.1371\/journal.pone.0014299","article-title":"Cytokine profiles in asthma families depend on age and phenotype","volume":"5","author":"Pukelsheim","year":"2010","journal-title":"PLoS One"},{"key":"key20200713100337_b40-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ni.2156","article-title":"IL-17C regulates the innate immune function of epithelial cells in an autocrine manner","volume":"12","author":"Ramirez-Carrozzi","year":"2011","journal-title":"Nat Immunol"},{"key":"key20200713100337_b41-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00403-010-1033-8","article-title":"Involvement of IL-17F via the induction of IL-6 in psoriasis","volume":"302","author":"Fujishima","year":"2010","journal-title":"Arch Dermatol Res"},{"key":"key20200713100337_b42-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"key20200713100337_b43-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"Chan","year":"2006","journal-title":"J Exp Med"},{"key":"key20200713100337_b44-etm-0-0-7624","first-page":"613086","article-title":"Genetics of psoriasis and pharmacogenetics of biological drugs","volume":"2013","author":"Prieto-P\u00e9rez","year":"2013","journal-title":"Autoimmune Dis"},{"key":"key20200713100337_b45-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1080\/09546630802206660","article-title":"Th17 cells: A new therapeutic target in inflammatory dermatoses","volume":"19","author":"Asarch","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"key20200713100337_b46-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J Invest Dermatol"},{"key":"key20200713100337_b47-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1365-2133.2008.08902.x","article-title":"Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin","volume":"160","author":"Johansen","year":"2009","journal-title":"Br J Dermatol"},{"key":"key20200713100337_b48-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1159\/000448090","article-title":"IL17A and IL17F gene polymorphism association with psoriasis risk and response to treatment in a Polish population","volume":"232","author":"Bia\u0142ecka","year":"2016","journal-title":"Dermatology"},{"key":"key20200713100337_b49-etm-0-0-7624","first-page":"119","article-title":"Escaping the economic turn down through performing employees, creative leaders and growth driver capabilities in the Romanian pharmaceutical industry","volume":"59","author":"Ra\u0163iu","year":"2011","journal-title":"Farmacia"},{"key":"key20200713100337_b50-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2217\/bmm.14.76","article-title":"Proteomics focusing on immune markers in psoriatic arthritis","volume":"9","author":"Caruntu","year":"2015","journal-title":"Biomarkers Med"},{"key":"key20200713100337_b51-etm-0-0-7624","first-page":"607","article-title":"Qualitative and quantitative determination of methotrexate polyglutamates in erythrocytes by high performance liquid chromatography","volume":"66","author":"Negrei","year":"2015","journal-title":"Rev Chim"},{"key":"key20200713100337_b52-etm-0-0-7624","first-page":"766","article-title":"Investigation relevance of methotrexate polyglutamates in biological systems by high performance liquid chromatography","volume":"66","author":"Negrei","year":"2015","journal-title":"Rev Chim"},{"key":"key20200713100337_b53-etm-0-0-7624","first-page":"767","article-title":"Acitretin treatment in psoriazis may influence the cell membrane fluidity","volume":"60","author":"Negrei","year":"2012","journal-title":"Farmacia"},{"key":"key20200713100337_b54-etm-0-0-7624","first-page":"1","article-title":"Systematic review of anti-drug antibodies of IL-17 inhibitors for psoriasis","volume":"18","author":"Thomas","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"key20200713100337_b55-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/JIR.S100940","article-title":"Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A","volume":"9","author":"Liu","year":"2016","journal-title":"J Inflamm Res"},{"key":"key20200713100337_b56-etm-0-0-7624","first-page":"1","article-title":"Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: Results from UNCOVER-2 and UNCOVER-3","volume":"4","author":"Kem\u00e9ny","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"key20200713100337_b57-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1512711","article-title":"UNCOVER-2 Study Group; UNCOVER-3 Study Group: Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"key20200713100337_b58-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(15)60125-8","article-title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials","volume":"386","author":"Griffiths","year":"2015","journal-title":"Lancet"},{"key":"key20200713100337_b59-etm-0-0-7624","first-page":"57","article-title":"Biosimilars: An update on clinical trials (review of published and ongoing studies)","volume":"25","author":"Olteanu","year":"2017","journal-title":"Acta Dermatovenerol Croat"},{"key":"key20200713100337_b60-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1086\/503821","article-title":"Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene","volume":"78","author":"Nair","year":"2006","journal-title":"Am J Hum Genet"},{"key":"key20200713100337_b61-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1111\/1346-8138.13412","article-title":"Genetic prediction of the effectiveness of biologics for psoriasis treatment","volume":"43","author":"Nishikawa","year":"2016","journal-title":"J Dermatol"},{"key":"key20200713100337_b62-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat Immunol"},{"key":"key20200713100337_b63-etm-0-0-7624","first-page":"918","article-title":"Original clinical experience and approach to treatment study with interleukin 12\/23 inhibitor in moderate-to-severe psoriasis patients","volume":"64","author":"Olteanu","year":"2016","journal-title":"Farmacia"},{"key":"key20200713100337_b64-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00296-012-2501-6","article-title":"IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population","volume":"33","author":"Catanoso","year":"2013","journal-title":"Rheumatol Int"},{"key":"key20200713100337_b65-etm-0-0-7624","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/105950","article-title":"Stress-induced mast cell activation in glabrous and hairy skin","volume":"2014","author":"C\u0103runtu","year":"2014","journal-title":"Mediators Inflamm"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:04:38Z","timestamp":1594631078000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":65,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7624","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]}}}